Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-03-11 to 2025-03-12
Current total value of award: $1818.72
Description: 4567565862!ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML